Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

A recent systematic review found that almost half of participants who take placebos in clinical trials experience drug related adverse events (AEs), with 5% of participants dropping out due to ‘drug related’ intolerance. However the placebo per se cannot be the cause of these adverse events. Instead, there are two overlapping likely explanations:

  1. Misattribution. A patient may have an underlying condition whose natural history produces some event (such as a headache), then the patient misattributes the event to the placebo.
  2. Nocebo effects. Having been warned about side effects in the patient information sheets, the patient may expect an adverse event. This negative expectation could then produce the event.

Nocebo effects may be caused—at least partly—by sharing information about AEs in the wrong way. This causes a tension between the ethical requirements of autonomy and non-maleficence. On the one hand, autonomy demands that patients be fully informed about treatment (adverse events). On the other hand, non-maleficence demands that patients be informed about AE’s in the right way. Ethical discussions of informed consent have focused almost exclusively on autonomy and may therefore been violating the requirement to do no harm. I will discuss ways in which autonomy and non-maleficence can be balanced in future clinical trials and ethical debates.

Forthcoming events

Festival of Global Health – Spillover: Planet of Viruses

Wednesday, 26 November 2025, 4pm to 8pm @ Curzon Oxford, Westgate Shopping Centre, Oxford OX1 1NZ

Oliver Smithies Lecture

Thursday, 27 November 2025, 5.15am to 6.15am @ Gillis Lecture Theatre

Talk title: Agency and Preference: Attitudes Toward Vaccination and Epidemic Risks

Optimising global frameworks for pandemic relevant research

Monday, 01 December 2025, 1pm to 2pm @ BDI/OxPop Seminar Rooms

IDEU Symposium 2026

Wednesday, 04 March 2026 to Thursday, 05 March 2026 @ Richard Doll Building - Lecture Theatre